BG103362A - Insulin c-peptides - Google Patents

Insulin c-peptides

Info

Publication number
BG103362A
BG103362A BG103362A BG10336299A BG103362A BG 103362 A BG103362 A BG 103362A BG 103362 A BG103362 A BG 103362A BG 10336299 A BG10336299 A BG 10336299A BG 103362 A BG103362 A BG 103362A
Authority
BG
Bulgaria
Prior art keywords
fragment
peptide
atpase activity
sequence
relates
Prior art date
Application number
BG103362A
Other languages
Bulgarian (bg)
English (en)
Inventor
John Wahren
Bo - Lennart JOHANSSON
Hans Joernvall
Original Assignee
Creative Peptides Sweden Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Creative Peptides Sweden Ab filed Critical Creative Peptides Sweden Ab
Publication of BG103362A publication Critical patent/BG103362A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/62—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
BG103362A 1996-09-27 1999-04-27 Insulin c-peptides BG103362A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9603533A SE520392C2 (sv) 1996-09-27 1996-09-27 Specifika peptider för behandling av diabetes mellitus
PCT/GB1997/002627 WO1998013384A1 (en) 1996-09-27 1997-09-26 Insulin c-peptides

Publications (1)

Publication Number Publication Date
BG103362A true BG103362A (en) 2000-05-31

Family

ID=20404052

Family Applications (1)

Application Number Title Priority Date Filing Date
BG103362A BG103362A (en) 1996-09-27 1999-04-27 Insulin c-peptides

Country Status (24)

Country Link
US (1) US6610649B2 (hu)
EP (1) EP0938503B1 (hu)
JP (1) JP2001500893A (hu)
KR (1) KR20000048643A (hu)
AT (1) ATE347562T1 (hu)
AU (1) AU741901B2 (hu)
BG (1) BG103362A (hu)
BR (1) BR9711573A (hu)
CA (1) CA2266416C (hu)
CZ (1) CZ108599A3 (hu)
DE (1) DE69737065T2 (hu)
DK (1) DK0938503T3 (hu)
ES (1) ES2278394T3 (hu)
HU (1) HUP0000432A3 (hu)
IL (1) IL129143A0 (hu)
IS (1) IS5008A (hu)
NO (1) NO991483L (hu)
NZ (1) NZ335231A (hu)
PL (1) PL332494A1 (hu)
RU (1) RU2206336C2 (hu)
SE (1) SE520392C2 (hu)
SK (1) SK39499A3 (hu)
TR (1) TR199900694T2 (hu)
WO (1) WO1998013384A1 (hu)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0022342D0 (en) * 2000-09-12 2000-10-25 Creative Peptides Sweden Ab Reduction of the electrocardiographic QT interval
DE10055857A1 (de) * 2000-11-10 2002-08-22 Creative Peptides Sweden Ab Dj Neue pharmazeutische Depotformulierung
US20030198666A1 (en) * 2002-01-07 2003-10-23 Richat Abbas Oral insulin therapy
US7384914B2 (en) * 2003-01-06 2008-06-10 Emisphere Technologies, Inc. Night-time oral insulin therapy
US20050026826A1 (en) * 2003-01-17 2005-02-03 Margarethe Hoenig Feline proinsulin, insulin and constituent peptides
US20050203001A1 (en) * 2004-03-05 2005-09-15 Emisphere Technologies, Inc. Oral insulin therapies and protocol
GB0323979D0 (en) 2003-10-13 2003-11-19 Creative Peptides Sweden Ab Therapeutic applications for c-peptide
EP1753446A4 (en) * 2004-05-27 2009-10-28 Essential Skincare Llc ALPHA-1 GLYCOPROTEIN ACID FOR THE TREATMENT OF DIABETES
US7833513B2 (en) 2004-12-03 2010-11-16 Rhode Island Hospital Treatment of Alzheimer's Disease
GB0601950D0 (en) * 2006-01-31 2006-03-15 Creative Peptides Sweden Ab Compositions and methods of treating diabetes
EP2054437A2 (en) * 2006-08-07 2009-05-06 Teva Biopharmaceuticals USA, Inc. Albumin-insulin fusion proteins
AU2008303925A1 (en) * 2007-09-11 2009-04-02 Mondobiotech Laboratories Ag Use of insulin C-peptide, alone or in combination with GLP-1, as a therapeutic agent
GB0723250D0 (en) * 2007-11-28 2008-01-09 Univ Leeds Compositions and methods for reducing macrovascular complications in diabetic patients
US20110165112A1 (en) * 2008-09-19 2011-07-07 Nektar Therapeutics Polymer conjugates of c-peptides
EP2341942A1 (en) 2008-09-19 2011-07-13 Nektar Therapeutics Polymer conjugates of therapeutic peptides
US8410049B2 (en) * 2009-10-28 2013-04-02 Cebix Methods and kits for preventing hypoglycemia
CN103119055A (zh) 2010-05-17 2013-05-22 塞比克斯公司 聚乙二醇化c肽
CN103458911B (zh) 2011-02-11 2016-02-24 密歇根大学董事会 肽组合物和用于治疗患者的方法
CA2855770A1 (en) 2011-11-17 2013-05-23 Cebix Ab Pegylated c-peptide
RU2522897C1 (ru) * 2013-04-16 2014-07-20 Закрытое акционерное общество "ФАРМ-ХОЛДИНГ" Твердая кишечнорастворимая лекарственная форма с-пептида проинсулина для перорального применения (варианты) и способ ее получения (варианты)
KR101676542B1 (ko) * 2014-12-30 2016-11-16 건국대학교 산학협력단 프로인슐린의 면역학적 용도
CN104888201B (zh) * 2015-06-29 2018-04-27 齐锦生 用于防治糖尿病及其慢性并发症的肽类药物
AU2018215245B2 (en) 2017-02-06 2024-07-11 Resiliun B.V. Interaction between C-peptides and elastin receptor, a model for understanding vascular disease

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU166913B (hu) * 1972-05-15 1975-06-28
JPS5210872B2 (hu) 1973-07-14 1977-03-26
JPS55105653A (en) * 1978-10-02 1980-08-13 Shionogi & Co Ltd Tyrosyl c-peptides
IL66611A0 (en) 1981-08-27 1982-12-31 Lilly Co Eli Pharmaceutical formulations comprising human insulin and human c-peptide
DE3326473A1 (de) 1983-07-22 1985-01-31 Hoechst Ag, 6230 Frankfurt Pharmazeutisches mittel zur behandlung des diabetes mellitus
US4581165A (en) 1984-06-14 1986-04-08 Eli Lilly And Company Anti-diabetic compounds
US5104854A (en) 1989-02-01 1992-04-14 Washington University Antiviral peptides
NZ232375A (en) 1989-02-09 1992-04-28 Lilly Co Eli Insulin analogues modified at b29
US5364757A (en) 1990-05-21 1994-11-15 Administrators Of The Tulane Educational Fund Methods of supporting a diagnosis of systemic lupus erythematosus
IL99699A (en) * 1990-10-10 2002-04-21 Autoimmune Inc Drug with the option of oral, intra-intestinal, or inhaled dosing for suppression of autoimmune response associated with type I diabetes
JPH05268982A (ja) 1992-03-27 1993-10-19 Hoechst Japan Ltd 骨形成作用を有する新規な蛋白質およびその製造法
CA2117904C (en) 1992-04-13 2004-06-22 John B. Harley Methods and reagents for diagnosis of autoantibodies
WO1994025071A1 (en) 1993-05-05 1994-11-10 Keith Rose Polyoxime compounds and their preparation
AT400723B (de) 1993-08-27 1996-03-25 Biomay Prod & Handel Rekombinante alternaria alternata allergene
CN1157621A (zh) 1994-07-08 1997-08-20 达特茅斯大学理事会 用于检测和治疗i型糖尿病的胰岛素原肽化合物
US6309853B1 (en) 1994-08-17 2001-10-30 The Rockfeller University Modulators of body weight, corresponding nucleic acids and proteins, and diagnostic and therapeutic uses thereof
GB9422175D0 (en) 1994-11-03 1994-12-21 Univ Dundee Indentification of the p21 waf1-pcna interaction site and therapeutic applications thereof
GB9509164D0 (en) 1995-05-05 1995-06-28 Smithkline Beecham Plc Novel compounds
AR006250A1 (es) 1996-03-15 1999-08-11 Corixa Corp Compuestos y metodos para la inmunoterapia e inmunodiagnostico del cancer prostatico
US6150500A (en) 1996-07-12 2000-11-21 Salerno; John C. Activators of endothelial nitric oxide synthase

Also Published As

Publication number Publication date
EP0938503B1 (en) 2006-12-06
AU4391597A (en) 1998-04-17
NZ335231A (en) 2000-11-24
DE69737065T2 (de) 2007-06-28
IS5008A (is) 1999-03-23
JP2001500893A (ja) 2001-01-23
SE520392C2 (sv) 2003-07-01
RU2206336C2 (ru) 2003-06-20
CA2266416A1 (en) 1998-04-02
US6610649B2 (en) 2003-08-26
TR199900694T2 (xx) 1999-06-21
NO991483L (no) 1999-05-18
IL129143A0 (en) 2000-02-17
AU741901B2 (en) 2001-12-13
NO991483D0 (no) 1999-03-26
SE9603533D0 (sv) 1996-09-27
DK0938503T3 (da) 2007-04-10
ATE347562T1 (de) 2006-12-15
US20020107175A1 (en) 2002-08-08
CZ108599A3 (cs) 1999-08-11
CA2266416C (en) 2008-04-29
DE69737065D1 (en) 2007-01-18
HUP0000432A2 (hu) 2000-08-28
BR9711573A (pt) 2000-01-18
HUP0000432A3 (en) 2000-10-30
SK39499A3 (en) 1999-10-08
WO1998013384A1 (en) 1998-04-02
KR20000048643A (ko) 2000-07-25
EP0938503A1 (en) 1999-09-01
ES2278394T3 (es) 2007-08-01
PL332494A1 (en) 1999-09-13
SE9603533L (sv) 1998-03-28

Similar Documents

Publication Publication Date Title
BG103362A (en) Insulin c-peptides
DE69531889D1 (de) Biologisch aktive Fragmente des Glucagon ähnlichen, insulinotropen Peptides
DE69833667D1 (de) Polynukleotid kodierend für ein polypeptid mit heparanase-aktivität und dessen expression in transduzierten zellen
ATE273996T1 (de) Zusammensetzung zur therapie von diabetes mellitus und fettsucht
NZ332879A (en) Use of fragments of leptin (ob protein) in medicaments for treating obesity or diabetes
ES2073571T3 (es) Aplicacion de nuevos fragmentos de adn como secuencia que codifica un peptido señal para la secrecion de proteinas maduras, mediante levaduras recombinantes, cassettes de expresion, levaduras transformadas y procedimiento correspondiente de preparacion de proteinas.
EP0919242A3 (en) Method for administering acylated insulin
NZ294743A (en) A formulation for administering transdermally a protein or polypeptide such as insulin
NZ504752A (en) Hydrophobically-modified protein compositions (particularly hedgehog proteins)
ATE447410T1 (de) Verwendung von humanem parathyroid-hormon
AU3346289A (en) Heparin-binding proteins, DNA coding for them, processes for producing them as well as therapeutic preparations containing them
BG104161A (en) Recombinant expression of insulin c-peptide
WO1999064598A3 (de) Neue insulinanaloga mit erhöhter zinkbindung
EP1132402A4 (en) PEPTIDE FRAGMENTS WITH CELL DEATH PREVENTIVE ACTIVITY
WO2003072126A3 (de) Verwendung eines fibroblastenwachstumsfaktor-bindeproteins zur behandlung und diagnose von diabetischen wundheilungsstörungen
ATE301712T1 (de) Z2-19a, ein menschliches homolog von dem protein 2-19
WO1999053064A3 (en) Methods of delivering glp-1
WO1999031229A3 (en) Peptides and nucleic acids derived from eisenia foetida and the use thereof
WO1999030670A3 (en) Methods of treatment using novel ligands of the neuropeptide receptor hfgan72 and agonists or antagonists thereof
WO2001032693A3 (de) Mit trp-proteinen verwandtes protein mtr1 und dieses codierende dna-sequenz
WO2003044159A9 (en) Zinc finger proteins, polynucleotides encoding same and antibodies thereto
AU7043301A (en) A novel polypeptide, a human protein 9 containing a fragment of p5cr specific sequence
WO2001047957A3 (en) Human fgf-10- (kgf-2)-like protein zfgf-10
WO1994015962A3 (en) Derivatized calcitonins
RU97102207A (ru) Белок мутантного человеческого гормона роста, дезоксирибонуклеотид, экспрессионная плазмида, продукт экспрессии, антитело, лекарственные средства